Showing 15 posts of 140 posts found.


How ‘deep reading’ of the scientific literature will benefit pharma

September 3, 2015
Research and Development Big Data, Cancer, Data Mining, R&D, literature search, oncology

The US Defense Advanced Research Projects Agency (DARPA)’s $45 million ‘Big Mechanism’ initiative has an ambitious aim.It promises to “leapfrog …

BioScience Nottingham

Nottingham receives go ahead for new £30m life science facility

August 19, 2015
Manufacturing and Production, Research and Development BioCity Nottingham, R&D

Hundreds of pharma jobs are expected to be created in Nottingham after the construction of a new £30 million life …

AstraZeneca plaque

Cambridge collaboration to boost precision medicine research

July 29, 2015
Research and Development Brabaham Institute, Cambridge, R&D, collaboration

A new consortium has been launched to act as a ‘match-making’ service between pharma companies and R&D researchers to develop …

Antibiotic resistance

Rising to meet the infectious disease challenge

July 27, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Antibiotics, R&D, antibiotic resistance, infectious disease

Antibiotic-resistant infections gather more headlines than most other infectious disease topics, and have typically been seen as a neglected area …

The Francis Crick Institute

GSK and the Francis Crick Institute collaborate on drug R&D

July 15, 2015
Research and Development Francis Crick Institute, GSK, R&D, The Crick, medical research

The UK’s largest pharma company and the UK’s newest biomedical research facility are partnering up to begin an innovation collaboration.The …

Public Health England

Public Health England and Imperial Innovations boost UK life sciences sector

July 14, 2015
Manufacturing and Production, Research and Development Imperial Innovations, Public Health England, R&D, investment, life sciences, spin-puts

The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …

Chancellor announces drug R&D funding boost in Catapult expansion

July 14, 2015
Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

Pharma companies look to Apple’s ResearchKit for R&D

July 13, 2015
Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit

Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …

Drug R&D

Pharma outsourcing: CROs, CMOs and external collaboration

July 2, 2015
Manufacturing and Production, Research and Development CMOs, R&D, clinical trials, collaboration, cros, outsourcing

Thirty years ago pharma companies seemed to use external contractors as a sort of fire brigade, to be called in …

Professor Dame Sally Davies

Pfizer partners with NIHR to boosts UK R&D

July 1, 2015
Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies

Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …

BMS image

BMS enters gene therapy development deal

April 7, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …

research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014
Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …

Teva image

Teva to ditch R&D in cancer and women’s health

October 6, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, MS, R&D, Teva, cuts, generics

Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …

AstraZeneca logo

AstraZeneca rejects Pfizer’s ‘final offer’

May 19, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover

AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …


BIA welcomes budget statement

March 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme

An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …

Latest content